Advertisement

Picture [iito] Fighting Customers 650x80px
All >

News > Collaborations

Find below news about collaborations, licenses, supplies in Europe and Israel or including organisations from these regions.

Total search results: 1945 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Evotec SE. (10/8/21). "Press Release: Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include Novel Cell Type". Hamburg. 2021-10-08
Pierre Fabre S.A.. (10/7/21). "Press Release: Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre". Victoria, BC & Castres. 2021-10-07
Merck KGaA. (10/5/21). "Press Release: Merck Licenses Foundational CRISPR Technology to Cellecta, Paving Path for Development of Next-Generation Treatments". Darmstadt. 2021-10-05
Atara Biotherapeutics, Inc.. (10/4/21). "Press Release: Atara Biotherapeutics and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel (Tab-cel)". South San Francisco, CA & Castres. 2021-10-04
BioNTech SE. (10/4/21). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union". New York, NY & Mainz. 2021-10-04
Agilent Technologies Inc.. (9/28/21). "Press Release: Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)". Santa Clara, CA. 2021-09-28
AstraZeneca plc. (9/23/21). "Press Release: AstraZeneca to Discover and Develop Self-amplifying RNA Therapeutics in New Collaboration with VaxEquity. AstraZeneca Will Invest in VaxEquity, an Imperial College Spin-off". 2021-09-23
Thermo Fisher Scientific Inc.. (9/23/21). "Press Release: First Net Zero Mass Spectrometer Launched to Support Greener Future". Bremen. 2021-09-23
VaxEquity Ltd.. (9/23/21). "Press Release: VaxEquity Announces Strategic Collaboration with AstraZeneca to Commercialise Self-Amplifying RNA Platform". London. 2021-09-23
Bico Group AB. (9/21/21). "Press Release: Bico Launches 3D Bioprinting Contract Research Offering from Cellink, MatTek and Visikol". 2021-09-21
Gubra ApS. (9/20/21). "Press Release: Gubra ApS and Bayer AG Collaborate to Develop Next Generation Cardiorenal Treatments". Hørsholm. 2021-09-20
Biognosys AG. (9/14/21). "Press Release: Biognosys Enters Collaboration with Leading Life Science Company to Advance Next-Generation Proteomics". Schlieren. 2021-09-14
ITM Isotopen Technologien München AG. (9/13/21). "Press Release: ITM and Chengdu Gaotong Isotope Co. Ltd. Form Joint Venture to Expand Access to ITM’s Diagnostic and Therapeutic Radioisotopes in China". 2021-09-13
Meatable. (9/13/21). "Press Release: Meatable Enters into Joint Development Agreement with Royal DSM to Develop Affordable Growth Media for Cultivated Meat". Amsterdam. 2021-09-13
Twist Bioscience Corporation. (9/9/21). "Press Release: Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration". South San Francisco, CA & Ingelheim. 2021-09-09
Exscientia Ltd.. (9/8/21). "Press Release: Exscientia Enters $70M Collaboration to Develop Anti-viral Therapeutics against Coronavirus and other Viruses with Pandemic Potential". 2021-09-08
Argenx SE. (9/3/21). "Press Release: Argenx to Present at Upcoming Investor Conferences". Breda. 2021-09-03
ImmunOs Therapeutics AG. (9/1/21). "Press Release: ImmunOs Therapeutics Appoints Jeffrey Abbey as Chief Operating Officer, Establishes Clinical Advisory Board". Schlieren. 2021-09-01
MedtecLIVE GmbH. (8/30/21). "Press Release: MedtecLIVE with T4M – Leading Springtime Event for Medical Technology Sector to Alternate between Stuttgart and Nuremberg". 2021-08-30
ADC Therapeutics S.A.. (8/26/21). "Press Release: ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million". Lausanne. 2021-08-26
MorphoSys AG. (8/26/21). "Press Release: MorphoSys and Incyte Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma". Plan 2021-08-26
Aptamer Group Ltd.. (8/25/21). "Press Release: Aptamer Group and Bio-Works Technologies Partner to Enable Improved Solutions for Gene Therapy Manufacturing". York & Uppsala. 2021-08-25
Cardior Pharmaceuticals GmbH. (8/25/21). "Press Release: Cardior Raises €64 M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease". Hanover. 2021-08-25
Zelluna Immunotherapy AS. (8/19/21). "Press Release: Exclusive License Agreement with the U.S. National Cancer Institute to Develop and Commercialize KK-LC-1 Targeting Allogeneic »Off-the-Shelf« TCR Based Natural Killer (TCR-NK) Cell Therapies". Oslo. 2021-08-19
Exscientia Ltd.. (8/18/21). "Press Release: Bristol Myers Squibb Exercises Option to Develop Exscientia’s AI-designed, Immune-modulating Drug Candidate". Oxford. 2021-08-18
Nanoform Finland Oyj. (8/17/21). "Press Release: Nanoform and Boehringer Ingelheim Execute Master Services Agreement". Munich. 2021-08-17
MorphoSys AG. (8/17/21). "Press Release: MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China". Planegg. 2021-08-17
ERS Genomics Ltd.. (8/17/21). "Press Release: ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement". Dublin & Coralville, IA. 2021-08-17
Berkeley Lights, Inc.. (8/11/21). "Press Release: Berkeley Lights and Bayer Announce a Multi-year Agreement Aimed at Revolutionizing the Discovery of Next-generation Traits". Emeryville, CA. 2021-08-11
Indivumed GmbH. (8/10/21). "Press Release: Veraxa Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody Drugs". Heidelberg & Hamburg. 2021-08-10
Mission Therapeutics Ltd.. (8/9/21). "Press Release: Mission and AbbVie Collaboration in Alzheimer’s and Parkinson’s Diseases Reaches Next Milestone- Mission Receives $20 Million Milestone payment". Cambridge. 2021-08-09
Qiagen N.V.. (8/9/21). "Press Release: Qiagen and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements". Hilden, Waltham, MA & Germantown, MD. 2021-08-09
Siemens Healthineers AG. (8/5/21). "Press Release: TeamViewer and Siemens Healthineers Form Partnership to Enable New Remote Scanning Service WeScan for Diagnostic Imaging". Erlangen & Göppingen. 2021-08-05
BRAIN Biotech AG. (7/28/21). "Press Release: Sartorius and BRAIN Jointly Researching and Adapting novel CRISPR Cas-nucleases". Göttingen & Zwingenberg. 2021-07-28
Atai Life Sciences N.V.. (7/28/21). "Press Release: Atai Life Sciences Launches InnarisBio, in Partnership with the University of Queensland". Berlin & Brisbane. 2021-07-28
Jeito Capital. (7/28/21). "Press Release: Jeito Capital’s Dr. Rafaèle Tordjman Appointed to Promote the French Biotech Ecosystem". Paris. 2021-07-28
Glycotope GmbH. (7/27/21). "Press Release: Byondis and Glycotope Enter Platform Access Agreement for Discovery and Development of Antibodies Against Novel GlycoTargets". Nijmegen & Berlin. 2021-07-27
Synaffix B.V.. (7/22/21). "Press Release: Synaffix Announces Deal with ProfoundBio Worth up to $246 Million Providing Access to Multiple Novel Linker-Payload Technologies". Amsterdam. 2021-07-22
EMBL. (7/22/21). "Press Release: DeepMind and EMBL Release the Most Complete Database of Predicted 3D Structures of Human Proteins". London. 2021-07-22
Exscientia Ltd.. (7/21/21). "Press Release: Exscientia and GT Apeiron Therapeutics Enter Oncology Joint Venture". Oxford & Shanghai. 2021-07-21
MorphoSys AG. (7/15/21). "Press Release: MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology". Planegg. 2021-07-15
Merck KGaA. (7/8/21). "Press Release: Merck and Inbrain Neuroelectronics Collaborate to Develop the Next Generation of Bioelectronic Therapies". Darmstadt. 2021-07-08
Thermo Fisher Scientific Inc.. (7/7/21). "Press Release: Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics". San José, CA & Davis, CA. 2021-07-07
Corat Therapeutics GmbH. (7/7/21). "Press Release: Corat Therapeutics GmbH Announces Partnership with Dermapharm Holding SE as Strong Strategic partner for the Further Development of COR-101". Braunschweig. 2021-07-07
Mimetas B.V.. (7/6/21). "Press Release: Mimetas and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development". Leiden. 2021-07-06
DKFZ (Deutsches Krebsforschungszentrum). (7/6/21). "Press Release: High-throughput Metabolic Profiling of Single Cells". 2021-07-06
Nvidia Corporation. (7/6/21). "Press Release: Nvidia Launches UK’s Most Powerful Supercomputer, for Research in AI and Healthcare". 2021-07-06
Max Planck Innovation GmbH. (7/5/21). "Press Release: Targeted Immune Stimulation for more Effective Vaccines. Cutanos, a Spin-off from the Max Planck Society, Is Developing Novel Vaccines and Immunotherapies". 2021-07-05
University of Paris. (7/5/21). "Press Release: Université de Paris – the Institut Pasteur Association. A World-class partnership in research and teaching in the field of health biology". Paris. 2021-07-05
High-Tech Gründerfonds Management GmbH. (7/5/21). "Press Release: Cutanos Closes First Financing Round with Investor Consortium from Austria and Germany". Vienna. 2021-07-05
Compass Pathways plc. (7/5/21). "Press Release: Compass Pathways Joins Forces with King’s College London and South London and Maudsley NHS Foundation Trust to Accelerate Psychedelic Research and Develop New Models of Mental Health Care in the UK". London 2021-07-05
Seres Therapeutics, Inc.. (7/1/21). "Press Release: Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement". Cambridge, MA & Lausanne. 2021-07-01
Merck KGaA. (6/29/21). "Press Release: Merck and B. Braun Join Forces in the Development of Bioelectronic Devices". Darmstadt. 2021-06-29
Cell and Gene Therapy Catapult, The. (6/29/21). "Press Release: Cell and Gene Therapy Catapult to Expand to Edinburgh BioQuarter". Edinburgh. 2021-06-29
Vivoryon Therapeutics N.V.. (6/29/21). "Press Release: Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China". Halle 2021-06-29
Aragen Life Sciences Pvt. Ltd.. (6/29/21). "Press Release: Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim". Hyderabad. 2021-06-29
Nucleai MD. (6/24/21). "Press Release: Nucleai and Merck KGaA Darmstadt, Germany Launch Translational Medicine Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform". Chicago, IL. 2021-06-24
Exscientia Ltd.. (6/24/21). "Press Release: EQRx and Exscientia Enter Strategic Drug Creation, Development and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines". Cambridge, MA & Oxford. 2021-06-24
908 Devices, Inc.. (6/22/21). "Press Release: 908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights". Boston, MA. 2021-06-22
Insilico Medicine Hong Kong Ltd.. (6/22/21). "Press Release: Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus". New York, NY & Hong Kong. 2021-06-22
Servier. (6/16/21). "Press Release: Servier and PRISM BioLab Enter Drug Discovery Collaboration for a Novel Target". Paris & Tokyo. 2021-06-16
Veraxa Biotech GmbH. (6/14/21). "Press Release: Veraxa Biotech and Quadira Biosciences Enter Partnership on ADC Development". Heidelberg. 2021-06-14
iTeos Therapeutics Inc.. (6/14/21). "Press Release: iTeos Therapeutics and GSK Announce Development and Commercialisation Collaboration for EOS-448, an anti-TIGIT Monoclonal Antibody, Enabling Novel Next-generation Immuno-oncology Combinations". Gosselie 2021-06-14
Evonik Industries AG. (6/10/21). "Press Release: Evonik and Stanford University Sign Research Collaboration – Evonik to Market and Develop New Drug Delivery Platform for mRNA and Gene Therapy". Essen. 2021-06-10
Argenx SE. (6/7/21). "Press Release: Argenx to Regain Global Rights to Cusatuzumab". Breda. 2021-06-07
KWS Saat SE & Co. KGaA. (6/7/21). "Press Release: RootCamp Gains KWS as New Corporate Partner". Hannover. 2021-06-07
Iksuda Therapeutics Ltd.. (6/7/21). "Press Release: Iksuda Therapeutics Closes $47 Million Financing Round". Newcastle. 2021-06-07
Proteros Biostructures GmbH. (6/2/21). "Press Release: Proteros Enters into Oncology Collaboration and License Agreement with AstraZeneca". Martinsried. 2021-06-02
Transine Therapeutics Ltd.. (6/2/21). "Press Release: Transine Therapeutics Closes Extended Seed Funding of £9.1 Million Co-led by Takeda Ventures, Inc. and the Dementia Discovery Fund to Advance Its Novel Class of Therapeutic RNAs". Cambridge. 2021-06-02
MorphoSys AG. (6/2/21). "Press Release: MorphoSys to Acquire Constellation Pharmaceuticals". Planegg & Cambridge, MA. 2021-06-02
Agilent Technologies Inc.. (6/1/21). "Press Release: Agilent Presents Thought Leader Award to Professor Chris Elliott". Santa Clara, CA. 2021-06-01
Merck KGaA. (5/27/21). "Press Release: Merck Collaborates with TU Darmstadt and Tufts University on Bioreactor Designs to Enable Cultured Meat Production". Darmstadt. 2021-05-27
Exscientia Ltd.. (5/19/21). "Press Release: Exscientia Announces Multi-target, AI-driven Drug Discovery Collaboration with Bristol Myers Squibb". 2021-05-19
Mestag Therapeutics Ltd.. (5/18/21). "Press Release: Mestag Therapeutics Announces Collaboration with Janssen, Focused on the Discovery of Novel Fibroblast Targets for the Treatment of Inflammatory Disease". Cambridge. 2021-05-18
BlueRock Therapeutics LP. (5/17/21). "Press Release: BlueRock Therapeutics, Fujifilm Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases". Cambridge, MA & Madison, WI. 2021-05-17
Exscientia Ltd.. (5/13/21). "Press Release: Exscientia Announces Second Molecule Created Using AI from Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial". 2021-05-13
MoonLake Immunotherapeutics AG. (5/6/21). "Press Release: MoonLake Immunotherapeutics Announces Publication in The Lancet". Zug. 2021-05-06
CRISPR Therapeutics AG. (5/6/21). "Press Release: CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer". Zug, Cambridge, MA & South San Francisco, CA. 2021-05-06
Kuur Therapeutics, Inc.. (5/4/21). "Press Release: Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform". Buffalo, NY. 2021-05-04
MoonLake Immunotherapeutics AG. (5/3/21). "Press Release: MoonLake In-licensing and Launch". Zug. 2021-05-03
Adcendo ApS. (4/29/21). "Press Release: Adcendo Raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers". Copenhagen. 2021-04-29
Twist Bioscience Corporation. (4/28/21). "Press Release: Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications". South San Francisco, CA & Frankfurt am Main. 2021-04-28
Inivata Ltd.. (4/28/21). "Press Release: Inivata and Agendia Sign Agreement for Commercialization of RaDaR MRD Liquid Biopsy Assay in Breast Cancer". Research Triangle Park, NC, Cambridge, Irvine, CA & Amsterdam. 2021-04-28
Kaia Health Software GmbH. (4/28/21). "Press Release: Kaia Health Raises $75 Million Series C to Optimize MSK and COPD Care in the U.S. and Europe". New York, NY. 2021-04-28
DNA Script. (4/27/21). "Press Release: DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA". Paris & Cambridge, MA. 2021-04-27
Bayer AG. (4/20/21). "Press Release: RAGT and Bayer Sign an Agreement to Develop Hybrid Wheat Seeds for European Markets". Rodez & Monheim. 2021-04-20
Relief Therapeutics Holding AG. (4/19/21). "Press Release: Relief Comments on Certain Statements Made by NeuroRx, Inc. in the Amended Form S-4 Filing of Big Rock Partners Acquisition Corp.". Geneva. 2021-04-19
Evotec SE. (4/19/21). "Press Release: Evotec Enters Partnership with Kazia Therapeutics for Clinical Development of EVT801". Hamburg. 2021-04-19
Alligator Bioscience AB. (4/15/21). "Press Release: Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy". Lund. 2021-04-15
Twist Bioscience Corporation. (4/14/21). "Press Release: Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities". South San Francisco, CA. 2021-04-14
Ori Biotech Ltd.. (4/14/21). "Press Release: ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers". London & Woodcliff Lake, NJ. 2021-04-14
Congenica Ltd.. (4/13/21). "Press Release: Congenica and Camtech Diagnostics Agree Strategic Partnership to Support Genomic Analysis Expansion in Asia". Cambridge & Singapore. 2021-04-13
Evotec SE. (4/13/21). "Press Release: Evotec Launches »beLAB2122«, Translating Academic Innovation from Leading German Life Science Region in Collaboration with Bristol Myers Squibb". Hamburg. 2021-04-13
Genovis AB. (4/13/21). "Press Release: Genovis and Waters Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization". 2021-04-13
Biognosys AG. (4/13/21). "Press Release: Biognosys Announces Strategic Agreement with Siemens Healthineers". 2021-04-13
Royal Philips. (4/8/21). "Press Release: Philips and Ibex Medical Analytics Team to Accelerate Adoption of AI-powered Digital Pathology". Amsterdam & Tel Aviv. 2021-04-08
Artios Pharma Ltd.. (4/7/21). "Press Release: Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies". Cambridge & New York, NY. 2021-04-07
Pyxis Oncology, Inc.. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA. 2021-03-30
ProBioGen AG. (3/24/21). "Press Release: ProBioGen Enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project". Berlin. 2021-03-24
Cytosurge AG. (3/24/21). "Press Release: Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks". Zürich. 2021-03-24
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  next pagenext page



Advertisement

Picture EBD Group BIO-Europe 2021 Time to Register 650x200

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture [iito] Back into Ad 650x80px

» top